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G PROTEIN-INDEPENDENT SIGNALING OF AT1-R 
 
 Angiotensin II (AngII) is the main regulator of the renin-angiotensin system 
and participates not only in physiological but also in pathological mechanisms. The 
type I angiotensin receptor (AT1-receptor) is a typical G protein-coupled receptor and 
largely acts via Gq activation upon agonist binding and these G protein-mediated 
„classical” signaling mechanisms are responsible for the most majority of AngII 
evoked cellular responses. Recently, new type of AT1-receptor mediated signaling 
mechanisms are discovered where the Ang II-induced signal transduction steps are not 
dependent on G protein coupling („G protein-independent”). By the help of the NNF-
OTKA grant, we investigated the G protein-independent signaling of AT1-receptor in 
living cells using wide range of molecular and cellular biology methods. All the 
experiments were performed in the Department of Physiology, Semmelweis 
University. 
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Results: 
Demonstration of Angiotensin II-Induced Ras Activation in the Trans-Golgi 
Network and the Endoplasmic Reticulum Using BRET-Based Biosensors 
 Since this work is already published in the Journal of Biological Chemistry, 
only a summary (without figures) is provided: 
 The small G-proteins such as Ras, Rho and Rac are central players of many 
signal transduction pathways and regulate a wide variety of cell functions. Recently 
discovered that extracellular stimuli of G-protein-coupled receptors, including AT1-
receptor can lead to activation of various small G-proteins. It is generally accepted 
that the signal generation of GPCRs occurs at the plasma membrane. Demonstration 
of the presence of signaling molecules in intracellular compartments raises the 
question, if signal generation can occur during receptor internalization. In order to 
investigate small G-protein activation upon agonist stimulus of AT1-receptor we have 
developed several intra- and intermolecular probes in bioluminescence resonance 
energy transfer (BRET), fluorescence resonance energy transfer (FRET) 
measurements and confocal microscopy in living cell experiments (Balla et al, JBC, 
2011) by the means of NNF-OTKA grant. We have also targeted our probes to 
various cellular locations thus we are able to monitor small G-protein activation in 
different plasma membrane and intracellular compartments. BRET probes report 
energy transfer from an energy donor (Renilla luciferase) to YFP when Ras become 
loaded with GTP and interacts with its effector during Ras activation. In our studies 
we used BRET measurements, since BRET has several advantages compared to 
FRET microscopy. For example, BRET is a more quantitative method, because it can 
be performed on large population of cells. BRET is also more sensitive compared to 
FRET, since the excitation light causes high background in FRET measurements. Our 
BRET probes were targeted to plasma membrane microdomains and intracellular 
organelles, including endoplasmic reticulum (ER), and trans-Golgi network (TGN), 
using specific targeting sequences to assess the effect of hormonal stimulation on Ras 
activity in these compartments. 
 AngII induced a transient Ras activation in the plasma membrane, which was 
much smaller compared to the EGF-induced response. This finding is consistent with 
the fact that EGF is a more effective Ras activator than AngII, however, it is possible 
that the incomplete transfection efficiency of the angiotensin receptor containing 
plasmid also contributed to this finding. Kinetically, EGF receptor activation also 
produced more prolonged Ras activation compared to the AngII-induced response. 
We were able to demonstrate that AngII stimulation not only increases Ras activity in 
the plasma membrane, but can also activate it in intracellular compartments, such as 
the TGN and the ER. We have also detected AngII-induced rapid and transient Ras 
activation in the TGN. AngII was a relatively efficient activator of Ras in the TGN, 
since the amplitude of the AngII and EGF responses in the TGN were comparable, 
whereas EGF caused a much larger response in the plasma membrane. AngII caused a 
more prolonged activation of Ras in the TGN in cells expressing the internalization-
deficient AT1A-R Δ319, which is consistent with the impaired desensitization of this 
receptor, and argue against the role of receptor endocytosis in AngII-induced Ras 
activation in the TGN. The Ras activation in the ER is surprising in many respects. It 
is remarkable that only AngII stimulus activated Ras, but EGF receptor stimulation 
was not able to produce this effect. This result provides evidence that the effect of 
AngII in the ER is independent of EGF receptor transactivation. Similar to the TGN, 
AngII caused a more prolonged activation of ER-targeted Ras in cells expressing the 
internalization-deficient AT1A-R Δ319, suggesting that the effect of AngII on Ras 
activation is also internalization independent in this compartment.  
 The mechanisms of AngII-induced Ras activation in the plasma membrane is 
cell type dependent. In vascular smooth muscle cells, and many other cell types 
transactivation of EGF receptors plays a major role in the mitogen effects of AngII. In 
our study AG1478, an EGF receptor kinase inhibitor, eliminated all EGF-induced 
responses, but had no effect on AngII-induced Ras activation in the Golgi and the ER, 
similar to that in the plasma membrane, in HEK293 cells. This finding is consistent 
with earlier studies, which demonstrated that AngII-induced ERK activation and 
mitogen signaling is independent of EGF receptor transactivation in these cells. 
Considering its rapid timing, it is likely that the effect of AngII on Ras activation in 
the TGN and the ER is mediated by soluble messengers, similar to the previously 
reported similar effects of growth factors and LPA. In cells expressing the 
internalization-deficient AT1A-R Δ319 mutant AngII caused more prolonged Ras 
activation both in the plasma membrane and in endomembranes, which is probably 
caused by the impaired desensitization of this mutant receptor. These data are also 
consistent with our conclusion that AngII-induced Ras activation in the Golgi and the 
ER is G protein mediated, and does not require receptor internalization or β-arrestin-
mediated signaling. 
 We did not detect significant AngII-induced Ras activation in cells expressing 
DRY/AAY mutant of AT1-R suggesting that the response, both in the plasma 
membrane and in endomembranes, is predominantly G protein mediated. We also 
have investigated the Ras activation by utilization of a biased AT1-receptor agonist, 
[Sar1,Ile4,Ile8]-AngII, which activates only G protein-independent pathways. In accord 
with the findings using DRY/AAY mutant of AT1-R, the [Sar1,Ile4,Ile8]-AngII 
stimulus did not yield significant Ras activation in HEK293 cells. We tried to measure 
Ras activation upon stimulus of endogenous AT1-receptor. We isolated smooth 
muscle cells from rats, but we were not able to detect significant Ras activation upon 
AngII treatment. It is likely, that the isolated cells lost their AT1-receptors during the 
cell grow since large number of cells is required for BRET experiments. 
 
Mapping of molecular dynamics of type I angiotensin receptor upon stimulus 
detected by bioluminescence resonance energy transfer-based sensors 
 Since this work is not yet published in peer-reviewed journal, a detailed report 
is provided: In the these sets of experiments we investigated the dynamics of AT1-
receptor movement, such as internalization or lateral movement between plasma 
membrane compartments upon hormone stimulus in BRET measurements. In order to 
analyze the G-protein independent components of AT1-receptor trafficking, we 
compared the data of AT1-receptor upon AngII or [Sar1,Ile4,Ile8]-AngII stimuli. We 
also investigated the effect of introducing DRY/AAY mutation into the receptor, 
hence we could measure the G-protein independent mechanisms in the molecular 
dynamics of AT1-receptor. Since, this work is not published yet, I would like to show 
our results in details: 
 The concept that the plasma membrane is not a uniform structure, but rather a 
mixture of microdomains has provided the possibility of compartmentalized signaling. 
The membrane rafts are specific microdomains of the plasma membrane and they 
differ in their compositions from the rest of the plasma membrane. These cholesterol- 
and sphingolipid-rich plasma membrane microdomains play important roles in 
compartmentalization of cellular functions. The membrane rafts are frequently 
referred as lipid rafts whereas the rest of the plasma membrane can called as non-lipid 
rafts or disordered membrane. Formation of rafts requires cholesterol and the 
cholesterol depletion by β-methyl-cyclodextrin (MβCD) treatment is widely used for 
lipid raft disruption. The membrane microdomains are located in both leaflets of the 
plasma membrane. It was also demonstrated by FRET approach that a lipid anchor on 
a fluorescent protein is sufficient to sequester to different microdomains within the 
plasma membrane. Zaccharias et al. constructed YFP fused with short peptides 
containing consensus sequences for acylation such as myristoylation and 
palmitoylation (MyrPalm-YFP, MP-YFP).  
 Although, the roles of membrane rafts are hot topics in the literature but their 
existence remain challenged. It is well established that some structural motifs of 
plasma membrane proteins are responsible for targeting into a membrane 
microdomains, and several membrane markers were recently developed to investigate 
membrane microdomains. Since the concept of membrane rafts are based on 
biochemical experiments utilizing various detergent extraction methods we decided to 
use other approach to investigate the relation of AT1-R to membrane microdomains in 
living cells. Earlier studies have demonstrated that AngII stimulation of AT1-R 
promotes its association and trafficking into caveolin-enriched/lipid rafts in vascular 
smooth muscle cells. Instead of focusing the characterization of the biophysical and 
biochemical nature of the plasma membrane microdomains during AT1-receptor 
action we followed the distribution of the AT1-receptor during its action. FRET and 
BRET based methods are widely used in GPCR research studies such as investigation 
of receptor oligomerization and lateral distribution of GPCRs. The main advantage of 
these methods that the measurements can be performed in living cells. We used 
several yellow fluorescent protein (YFP)-labeled fusion constructs (i.e. raft-, or non-
raft plasma membrane markers) to analyze the dynamics of AT1-R movement, such as 
internalization or lateral movement between plasma membrane compartments upon 
stimulus in BRET measurements. The BRET probes are report energy transfer from 
an energy donor (Renilla luciferase) to an acceptor (YFP). When the luciferase is 
close to the YFP we can detect BRET signal and upon diverge from each other (or if 
the orientation is changed) the BRET ratio signal drops. In contrast to that, when 
luciferase and YFP come up closer to each other an elevated BRET ratio signal can be 
detected. 
 We constructed numerous constructs by the help of NNF-OTKA grants. We 
used the eYFP-C1 or eYFP-N1 plasmid backbone for the construction of YFP labeled 
constructs. AT1R-Rluc was constructed by replacing the eYFP coding region in 
AT1R-YFP with Renilla luciferase. The luciferase tagged 5-hydroxytryptamine 
receptor-2C receptor (5HT-2CR) was constructed by subcloning the receptor cDNA 
into the codon humanized Renilla luciferase pRluc-N1 vector. The luciferase tagged 
epidermal growth factor receptor (EGFR) was constructed by replacing the eYFP 
coding region in EGFR-YFP with Renilla luciferase. The MP (MyrPalm) and PP 
(PalmPalm) targeting was the N-terminal MGCIKSKRKDNLNDDE amino acid 
sequence from Lyn kinase, and PP was the N-terminal MLCCMRRTKQ amino acid 
sequence from Gap43. In order to target the eYFP to the disordered plasma membrane 
microdomain, we have fused C-terminally the CAAX motif from K-Ras small G 
protein (tK stands for the K-Ras CAAX targeting motif, tail K-Ras), 
KMSKDGKKKKKKSKTKCVIM consists of the membrane targeting CAAX motif 
and hypervariable regions of K-Ras. The DRY/AAY mutation of the AT1A-R (the 
highly conserved D125R126Y127 was mutated to A125A126Y127) and the TSTS/A mutant 
of the AT1A-R (the T332S335T336S338 were substituted with alanine) were described 
earlier. The experiments were performed on HEK293 cell line. The cells were 
cultured in DMEM with Pen/Strep and 10% heat-inactivated fetal bovine serum in 5% 
CO2 at 37 oC. The cells were cultured in plastic dishes and were trypsinized prior to 
transfection and were transiently transfected by using Lipofectamine 2000 and plated 
on poly-lysine pretreated white 96-well plates in 1x105 cells/well density for BRET 
measurements. The DNA amounts were 0.25 μg Rluc containing construct/well and 
0.0625 μg YFP containing construct/well; the amount of Lipofectamine 2000 was 0.5 
μl/well. The BRET measurements were performed after 24 h of the transfection on 
white 96-well plates. The medium of the cells were changed prior to measurements to 
a modified Krebs-Ringer buffer containing 120 mM NaCl, 4.7 mM KCl, 1.8 mM 
CaCl2, 0.7 mM MgSO4, 10 mM glucose, and Na-HEPES 10 mM, pH 7.4; and the 
BRET measurements were performed at 37 oC. The BRET measurements were started 
after addition of the cell permeable substrate, coelenterazine at a final concentration of 
5 μM, and the counts were recorded by using Berthold Mithras LB 940 multilabel 
reader that allows for the detection of signals using filters at 485 and 530 nm 
wavelengths, the detection time was 0.25-0.5 sec. The BRET ratios were calculated as 
530 nm/485 nm ratio. Measurements were done in triplicate. The BRET records are 
average of at least 3 independent experiments. BRET ratios were baseline-corrected to 
the vehicle curve using GraphPad Prism software. The approximate BRET ratio using 
the cytosolic eYFP (unbiased) and AT1R-Rluc pair is ~0.85. The localization and 
distribution of the targeted probes was analyzed using Zeiss LSM 510 confocal laser-
scanning microscope in living cells plated on poly-lysine pretreated glass coverslips 
(3x105 cells/35-mm dish). 
 BRET assay for detection of dynamics of AT1-R: To detect the movement of 
AT1-R upon stimulus, our strategy was to use Renilla luciferase labeled AT1-R and 
we followed the BRET ratio between the AT1-R and a YFP labeled protein 
counterpart. When the HEK293 cells co-expressing wild type AT1-R-luciferase and 
arrestin-YFP were exposed to 100 nM AngII the BRET ratio (Fig. 1A, filled 
rectangles) elevated between the arrestin-YFP and wild-type AT1-R-luciferase 
showing that the β-arrestin binds to the activated AT1-R. The internalized AT1-R then 
appears in the endocytotic route, which could be detected with the energy transfer 
between the Rab5-YFP (as early endosome marker) and the wild-type AT1-R-
luciferase (Fig. 1B, filled rectangles). When the plasma membrane marker MP-YFP 
was used the BRET ratio dropped upon stimulus of the wild type AT1-R-luciferase 
(Fig. 1C, filled rectangles), but in contrast to that, when KR-YFP (also plasma 
membrane located similar to MP-YFP) was used we measured a significant BRET 
signal elevation prior to drop in BRET ratio (Fig. 1D, filled rectangles). We think that 
the observed changes in the BRET ratio upon stimulus of AT1-R-luciferase using 
either MP-YFP or KR-YFP are not consequence of the high protein overexpression. 
The gradual reduction of the DNA amounts used for the transfection, resulting very 
low counts in the BRET measurements, did not alter the shapes and extents of the 
BRET ratio changes (data not shown). Since the cytosolic YFP and AT1-R are not in 
the same compartment, the stimulus of the AT1-R-luciferase by 100 nM AngII did not 
change the BRET ratio (Fig. 1E, filled rectangles). 
 Molecular dynamics of mutant AT1 receptors: The dissimilar BRET curves of 
MP-YFP or KR-YFP raised the possibility that we could monitor the movement of 
AT1-R between different plasma membrane compartments in living cells immediately 
in response to agonist stimulus. We further investigated whether the dynamics of the 
receptor is altered using mutant AT1-Rs (Fig. 1 open rectangles, dotted lines: 
DRY/AAY AT1-R; open circles: TSTS/A AT1-R). It was revealed that the dynamics 
of DRY/AAY AT1-R is dramatically changed compared to wild type AT1-R. When 
the DRY/AAY AT1-R-luciferase was exposed to 100 nM AngII, the β-arrestin 
binding capability of the Ang II-bound DRY/AAY mutant receptor is slightly 
decreased (Fig. 1A, open rectangles, dotted lines). The AngII stimulated DRY/AAY 
mutant receptor was also able to translocate to Rab5 endocytic compartments (Fig. 
1B, open rectangles, dotted lines). Moreover, the BRET ratio drop with MP-YFP is 
more immediate using DRY/AAY AT1R-luciferase (Fig. 1C, open rectangles, dotted 
lines) compared to wild type AT1-R-luciferase was used the BRET ratio (Fig. 1C, 
filled rectangles). Using the DRY/AAY AT1-R-luciferase and the KR-YFP the BRET 
ratio (Fig. 1D, open rectangles, dotted lines) decreased without the initial elevation 
compared to the results using the wild type AT1 receptor after the stimulus of 
HEK293 cells with 100 nM AngII (Fig. 1D, filled rectangles). We also determined the 
molecular dynamics of another AT1-R mutant, TSTS/A mutant which is not able to 
bind β-arrestin and its internalization is significantly reduced in response to AngII 
stimulus (Fig. 1A and 1B, open circles). Since the internalization of the TSTS/A AT1-
R is reduced compared to wild type AT1R, the slow decrease in BRET ratios are 
reduced (Fig. 1C and 1D, open circles). We think that the slow decrease component of 
the BRET signal is the consequence of the internalization of the AT1-R, which results 
in diminishing AT1-R from the plasma membrane. This assumption is confirmed 
using AT1-R-luciferase and PLCδ1-PH-YFP as BRET pairs. 
 
 
Figure 1. BRET assay between AT1-R and different proteins upon AngII stimulus in 
HEK293 cells. HEK293 cells were transfected with the plasmids of the indicated AT1-
R-luciferase (filled rectangles: wild type; open rectangles, dotted lines: DRY/AAY 
mutant; open circles: TSTS/A mutant) and with the indicated YFP fused proteins, and 
after 24 hours the cells were exposed to 100 nM AngII or vehicle (dashed line) at the 
indicated time points. The BRET records are average of 3 independent experiments. 
Mean values ± SEM are shown (n = 3). 
 
When the HEK293 cells co-expressing wild type AT1-R-luciferase and PLCδ1-PH-
YFP were exposed to 100 nM AngII the BRET ratio dropped very quickly then the 
ratio started to increase (Fig. 1F, filled rectangles). This initial drop shows that the 
AT1R-luciferase and the PLCδ1-PH-YFP diverged from each other then they started 
to approach other. The PH domain of PLCδ1 is a marker for PtdIns(4,5)P2  in the 
plasma membrane. The initial drop in the BRET signal reflects that the agonist 
stimulus of AT1-R cause PtdIns(4,5)P2 breakdown via Gq, which results the release of 
PLCδ1-PH-YFP from the plasma membrane. After short period of time the ratio 
begins to elevate since the PtdIns(4,5)P2 resynthesis occurs very rapidly and the 
PLCδ1-PH-YFP rebinds to the plasma membrane. This elevation in the BRET signal 
is followed by a slow decrease, which suggests that the AT1-R-luciferase and the 
PLCδ1-PH-YFP starts to diverge from each other again because of the receptor 
internalization. When the HEK293 cells co-expressing DRY/AAY AT1-R-luciferase 
and PLCδ1-PH-YFP was exposed to 100 nM AngII the BRET ratio decreased 
continually without a peak in the drop (Fig. 1F, open rectangles, dotted line). This 
reflects the fact that the stimulus of the DRY/AAY AT1-R does not result 
PtdIns(4,5)P2 breakdown (release of PLCδ1-PH-YFP from the plasma membrane, 
Fig. 1F) but the DRY/AAY AT1-R internalizes upon stimulus (Fig. 1B, open 
rectangles, dotted lines). 
 Distribution of plasma membrane makers upon agonist stimulus: We 
examined the distribution of MP-YFP, PLCδ1-PH-YFP, and KR-YFP in HEK293 
cells in response to AngII stimulus. As shown in the Fig. 2, the AngII stimulus did not 
alter noticeably the distribution and amount of MP-YFP or KR-YFP in the plasma 
membrane. In contrast to that the PLCδ1-PH-YFP temporarily is translocated to the 
cytoplasm and then returns to the plasma membrane reflecting the PtdIns(4,5)P2 level 
in the plasma membrane. Taken together, it seems that the changes in the BRET ratio 
using MP-YFP or KR-YFP along with AT1-R-luciferase reflect the alterations in the 
AT1-R distribution and not the changes in the using MP-YFP or KR-YFP distribution 
in the plasma membrane. 
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Figure 2. Effects of 100 nM AngII stimulus on the distribution of MP-YFP, PLCδ1-
PH-YFP, and KR-YFP in HEK293 cells. The cells were transfected with the AT1-R-
luciferase and with the indicated YFP fused proteins. After 24 hours the cells were 
exposed to 100 nM AngII. The probes were visualized by laser scanning confocal 
microscopy (Zeiss LSM510). The representative confocal micrographs show the 
localization and cellular distribution of the indicated probes before (0 sec) and 20 sec 
or 300 sec after the AngII treatment. The YFP fluorescence was detected by Zeiss 
LSM 510 confocal microscope. Bars: 10 μm. 
 
 Effect of cholesterol depletion on the AT1-R motion upon agonist stimulus: We 
next tested whether the integrity of lipid rafts is required for the observed molecular 
dynamics of the AT1-R. We used a widely used method, the cholesterol depletion with 
β-methyl-cyclodextrin (MβCD) treatment for lipid raft disruption. In the presence of 
MβCD, the motion of AT1-R is greatly altered. The significant BRET signal elevation 
prior to drop in BRET ratio between KR-YFP and AT1-R-luciferase (Fig. 3B, filled 
rectangles) was totally eliminated in case of MβCD pretreatment (Fig. 3B, open 
rectangles, dotted line). The β-arrestin binding was also affected (Fig. 3C). 
 
Figure 3. Effect of MβCD treatment on the AT1-R motion upon agonist stimuli. 
HEK293 cells were transfected with the plasmids of the AT1-R-luciferase and the 
indicated YFP fused proteins, and after 24 hours the cells were were pretreated for 30 
min prior to BRET measurement in absence (filled rectangles) or presence of 10 μM 
MβCD (open rectangles). After pretreatment the cells were exposed to either 100 nM 
AngII or vehicle (dashed line) at the indicated time points. The BRET records are 
average of 3 independent experiments. Mean values ± SEM are shown (n = 3). 
 
 
 Molecular dynamics of AT1 receptors using various ligands: We further 
investigated whether the binding of different ligands to the AT1-R causes dissimilar 
dynamics upon stimulus. The [Sar1,Ile4,Ile8]-AngII (SII-AngII) is a biased AT1-R 
agonist, which is not able to activate G proteins, but can stimulate G protein-
independent mechanisms such as β-arrestin-binding and ERK activation. The stimulus 
of AT1-R with that analogue caused altered dynamics of AT1-R compared to AngII 
(Fig. 4).  It is shown in the Fig. 4A and 4B that motion of the AT1-R is impaired using 
SII-AngII, but the receptor is able to be internalized, which is consistent with previous 
report that the SII-AngII can induce AT1-R internalization. It is noticeable that the 
BRET ratio drop with the MP-YFP is more immediate using SII-AngII stimulus (Fig. 
4A, green trace) than using AngII (Fig. 4A, red trace). It is also very apparent that the 
BRET ratio between KR-YFP and AT1-R-luciferase upon SII-AngII treatment 
decreased immediately, without the initial elevation compared to AngII stimulus (Fig. 
4B). It seems that the rapid motion of AT1-R-luciferase in response to AngII between 
plasma membrane markers is G protein-dependent and/or reflects the different 
conformational change of the receptor using distinct ligands. The AT1-R-luciferase 
binds β-arrestin in less degree by SII-AngII than AngII stimulus (Fig. 4C). The BRET 
ratio between Rab5-YFP and AT1R-luciferase upon SII-AngII treatment is elevated 
more significantly by SII-AngII than AngII stimulus (Fig. 4D), which is similar to the 
results using Rab5-YFP and DRY/AAY AT1R-luciferase upon Ang II (Fig. 1B). Since 
the SII-AngII stimulus of AT1-R does not activate Gq mediated PtdIns(4,5)P2 
breakdown, the BRET ratio with the PLCδ1-PH-YFP decreases continually without 
an initial peak in the drop (green trace, Fig. 4E). The [Sar1,Ile8]-AngII (SI-AngII) is 
an octapeptide angiotensin analogue, which is an AT1-R antagonist, and was shown 
earlier that is able to initiate receptor internalization. The stimulus of AT1-R-
luciferase with SI-AngII also caused altered dynamics of the receptor compared to 
AngII stimulus (Fig. 4). The results after SI-AngII stimulus of the AT1-R-luciferase 
using either MP-YFP or KR-YFP are similar (green trace, Fig. 4A and B) that 
supports the idea that proper dynamics of AT1-R upon stimulus between plasma 
membrane markers is G protein-dependent and/or requires physiological 
conformational change of the receptor. Since the SI-AngII is an AT1-R blocker, the 
stimulus with this analogue does not result PtdIns(4,5)P2 hydrolysis (blue trace, Fig. 
4B). 
 
 
Figure 4. BRET assay between AT1-R and different proteins upon stimulus in 
HEK293 cells. HEK293 cells were transfected with the plasmids of the AT1-R-
luciferase and the indicated YFP fused proteins, and after 24 hours the cells were 
exposed to either 100 nM AngII (red trace), or 100 nM SI-AngII (blue trace), or 10 
μM SII-AngII (black trace), or vehicle (dashed line) at the indicated time points. The 
BRET records are average of 3 independent experiments. Mean values ± SEM are 
shown (n = 3). 
 
 BRET assay for detection of dynamics of 5HT-2C-R and EGF-R: The 
preceding results suggest that the molecular dynamics of a plasma membrane receptor 
could be mapped by the very sensitive BRET technique. Next, we explored our BRET 
measurements to other receptors in order to test whether we could detect similar 
dynamics upon agonist stimulus. We measured the motion of 5HT-2C-receptor (Fig. 
5) and EGF receptor (Fig. 6) upon agonist stimuli. The 5HT-2CR is also couples to Gq 
protein, similarly to the AT1-R. After 5-hydroxytryptamine (5HT) binding, the 
receptor binds to β-arrestin (Fig. 5C), and gets internalized on the basis of BRET ratio 
elevation between Rab5 and 5HT-2CR (Fig. 5D). The internalization is also apparent 
using the plasma membrane located MP-YFP and KR-YFP (Fig. 5A and 5B), but we 
could not detect strikingly different distribution change between using MP-YFP and 
KR-YFP dissimar to AT1-R. The EGF receptor belongs to the Receptor Tyrosine 
Kinase class of receptors, and is widely used for the study of receptor internalization. 
In contrast to AT1-R and, which are GPCRs, the EGF-R does not interact with β-
arrestin (Fig. 6C), but internalizes upon EFG treatment (Fig. 6D). Similarly to 5HT-
2C-R, we also did not observe different distribution change between using MP-YFP 
and KR-YFP with EGFR-luciferase (Fig. 6A and 6B). Disruption of lipid rafts by 
MβCD pretreatment did not yield dramatic change in the dynamics of either 5HT-2C-
R (Fig. 5, open circles) or EGF-R (Fig. 6, open circles). 
  
 
Figure 5. BRET assay between 5HT-2C-receptor and different proteins upon stimulus 
in HEK293 cells. HEK293 cells were transfected with the plasmids of the 5HT-2C-R-
luciferase and the indicated YFP fused proteins, and after 24 hours the cells were 
pretreated for 30 min prior to BRET measurement in absence (filled rectangles) or 
presence of 10 μM MβCD (open rectangles). After pretreatment the cells were 
exposed to 10 μM 5HT or vehicle (dashed line) at the indicated time points. The 
BRET records are average of 3 independent experiments. Mean values ± SEM are 
shown (n = 3). 
  
 Our BRET experiments indicate that the localization of the AT1-R rapidly 
changes after AngII stimulus in HEK293 cells. Comparing the data, which were 
obtained utilizing either wild type or mutated AT1-R co-expressed with the 
fluorescent probes in HEK293 cells revealed change in distribution between 
membrane microdomains in response to AngII stimulus. The dynamics of DRY/AAY 
AT1-R, which is not able to activate Gq protein, is dramatically changed compared to 
wild type AT1-R. The stimulus of the DRY/AAY AT1-R did not result PtdIns(4,5)P2 
breakdown thus release of PLCδ1-PH-YFP from the plasma membrane but the 
DRY/AAY AT1-R internalizes upon stimulus. The β-arrestin binding of the Ang II-
bound DRY/AAY mutant receptor is G protein-independent. It seems that the rapid 
motion of AT1-R-luciferase in response to AngII stimulus between plasma membrane 
markers is G protein-dependent. The BRET ratio between DRY/AAY AT1-R-
luciferase and the KR-YFP decreased without the initial elevation compared to wild 
type AT1 receptor, and the BRET ratio drop with MP-YFP is more immediate using 
DRY/AAY AT1R-luciferase than using wild type AT1-R-luciferase. TSTS/A AT1-R is 
not able to bind β-arrestin and its internalization is significantly reduced in response 
to AngII. We also confirmed these properties of this mutant. Since the internalization 
of the TSTS/A AT1-R is reduced compared to wild type AT1-R, the slow decrease 
component, which is considered as the internalization component, is reduced. We also 
revealed that the dynamics of AT1-R is different using diverse ligands of the receptor. 
The stimulus of AT1-R with either [Sar1,Ile8]-AngII or [Sar1,Ile4,Ile8]-AngII caused 
altered dynamics of AT1-R compared to AngII. The biased agonist SII-AngII is not 
able to activate G proteins, but can stimulate G protein-independent mechanisms such 
as β-arrestin-binding and ERK activation. 
 
 
Figure 6. BRET assay between EGF-receptor and different proteins upon stimulus in 
HEK293 cells. HEK293 cells were transfected with the plasmids of the EGF-R-
luciferase and the indicated YFP fused proteins, and after 24 hours the cells were 
pretreated for 30 min prior to BRET measurement in absence (filled rectangles) or 
presence of 10 μM MβCD (open rectangles). After pretreatment the cells were 
exposed to 50 ng/ml EGF or vehicle (dashed line) at the indicated time points. The 
BRET records are average of 3 independent experiments. Mean values ± SEM are 
shown (n = 3). 
 
 
According to our data, the rapid motion of AT1-R-luciferase upon stimulus between 
plasma membrane markers is G protein-dependent or reflects the different 
conformational change of the receptor using distinct ligands. The binding of an 
antagonist (SI-AngII) to AT1-R caused altered dynamics of the receptor compared to 
AngII stimulus that supports the idea that proper dynamics of AT1-R upon stimulus 
between plasma membrane markers requires physiological conformational change of 
the receptor. We have also demonstrated that the dynamics of AT1-R upon agonist 
stimulus is cholesterol-sensitive since it is considerably affected by MβCD treatment. 
These results suggest that the integrity of lipid rafts is required for normal AT1-R 
dynamics. We also examined of the molecular dynamics of other receptors, such as 
5HT-2C- and EGF receptor. It is important to note that the dynamics of the AT1-R is 
strikingly different from 5HT-2C-R and EGF-R, which shows the usefulness of the 
BRET based approach to investigate receptor dynamics between membrane 
microdomains in living cell experiments. 
 
 Taken together, these studies provided better understanding of G protein-
independent signaling of AT1-receptor, and the better understanding of the signaling 
properties of AT1-receptor may provide additional clues to improve the therapeutic 
potential of drugs that target this receptor which can lead to the development of new 
pharmacological tools for the treatment of cardiovascular disease. The studies 
demonstrate the wide scale effects of AngII on Ras activation, and underline that Ras 
can signal from distinct compartments of cellular membranes to ensure functional 
diversity but not redundancy of its signaling. We also provided valuable information 
about the distribution and dynamics of AT1-receptor upon ligand binding among 
membrane microdomains, and revealed G protein-independent mechanisms in the 
dynamics of the AT1-receptor in living cell experiments. 
